Intranasal interferon (rIFN-αA, Ro 22-8181) for contact prophylaxis against common cold: A randomized, double-blind and placebo-controlled field study
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 6 (3) , 171-176
- https://doi.org/10.1016/0166-3542(86)90011-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intranasal Interferon- 2 Prophylaxis of Natural Respiratory Virus InfectionThe Journal of Infectious Diseases, 1985
- Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha2 in natural respiratory viral infectionsAntiviral Research, 1985
- Intranasal Interferon- 2, Treatment of Experimental Rhinoviral ColdsThe Journal of Infectious Diseases, 1984
- The Common Cold: Control?The Journal of Infectious Diseases, 1984
- Intranasal interferon-alpha 2 for prevention of natural rhinovirus coldsAntimicrobial Agents and Chemotherapy, 1984
- INTRANASAL INTERFERON FOR CONTACT PROPHYLAXIS AGAINST COMMON COLD IN FAMILIESThe Lancet, 1983
- Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha2Antiviral Research, 1983
- PREVENTION OF RHINOVIRUS COLDS BY HUMAN INTERFERON ALPHA-2 FROM ESCHERICHIA COLIThe Lancet, 1982
- INHIBITION OF RESPIRATORY VIRUS INFECTION BY LOCALLY APPLIED INTERFERONThe Lancet, 1973